Matthew Gubens

A clinical investigator from the University of California, San Francisco specializing in immunotherapy and lung cancer.

Best podcasts with Matthew Gubens

Ranked by the Snipd community

Jul 30, 2024 • 1h 1min

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer

Dr. Matthew Gubens, a clinical investigator from UCSF specializing in immunotherapy, discusses pivotal 2023 breakthroughs in treating non-small cell lung cancer (NSCLC) without actionable mutations. He highlights the evolution of immunotherapy, addressing challenges like colitis linked to genetic risk. Gubens also explores the impact of circulating tumor DNA on treatment choices and patient advocacy in complex cases. The conversation covers the potential of new therapies, including bispecific antibodies and antibody-drug conjugates, reshaping lung cancer treatment.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

App store banner

Play store banner